Abstract:OBJECTIVE: When preliminary tests have confirmed a nano-hydroxyapatite (Nano-HA) content of 20% of the polylactic acid (PLA) composite material of Nano-HA interface fixation material for biomechanical requirements, there is a need for further observation of its biocompatibility and clinical applications, to provide reference data.METHODS: Preparation of Nano-HA content of 20% PLA composite Nano-HA bone substitute material and extract. The establishment of the negative control group (containing 10% fetal bovine serum in DMEM complete medium), experimental group (extract), the positive control group (mass concentration of 0.64% phenol), and a co-culture of rabbit bone marrow mesenchymal stem cells (rBMSC) and materials extraction liquid. Observation of the morphological changes in rBMSC in culture at time points of 3, 5, and 7 days, the use of the MTT assay, and determination of the relative growth in the above set of rBMSC in cell culture at 3, 5, and 7 days, to judge the material's cytotoxicity.RESULTS: With time, the absorbance value of the three groups of cells were significantly increased (P < 0.01). The relative growth of the rBMSCs in experimental group in the first 3, 5, and 7 days was 95.3%, 96.8% and 97.6%; the cytotoxicity was according to the national standards I; the difference was not significant (P > 0.05) between the the experimental group and the negative control group; there was a significant difference between the positive control group and the other 2 groups (P < 0.05). Cells in the experimental group were seen having normal morphology, and spindle-shaped adherent growth.CONCLUSION: PLA composite artificial bone materials and Nano-HA show good cell compatibility, and the values for cytotoxicity, with reference to GB/T16886.5.2003 (China) standards, are in the safe range.

Celluar compatibilty of the nano-hap/collagen and bone marrow stem cell

The Comparative Study on the Biocompatibility of Four Kinds of Scaffolds

Cellular compatibility of nano-hydroxyapatite/collagen/calcium aiginate and bone marrow stem cells

Biocompatibility of Nano-Hap/Collagen and Rabbit Bone Mesenchymal Stem Cells

Cell Biocompatibility of Hydroxyapatite/Silk Fibroin Composite Scaffolds Carrying Bone Morphogenetic Protein

Biocompatibility of the nano-hydroxyapatite/chitosan composite and rabbit bone marrow stem cells

Cytocompatibility of nano-hydroxyapatite/bacterial cellulose nanocomposites and its residues

Controllable Synthesis Of Spherical Nano Hydroxyapatites And Their Effects On Growth And Osteogenic Differentiation Of Bone Marrow Derived Mesenchymal Stem Cells

Biocompatibility of the Injectable Nano Tissue-Engineered Bone

In vitro cytotoxicity study of the nano-hydroxyapatite/bacterial cellulose nanocomposites

Attachment And Proliferation Of Mouse Bone Marrow Stem Cells On Electrospun Chitosan-Based Nanofibrous Scaffolds

Nano-hydroxyapatite/collagen Composite for Bone Repair

Cytocompatibility of PLA/Nano-HA composites for interface fixation

Assessment of the Biocompatibility Ability and Differentiation Capacity of Mesenchymal Stem Cells on Biopolymer/Gold Nanocomposites

The experimental study on the osteogenesis of the nHAC/CF in vivo and vitro

[Biocompatibility of Alpha-Calcium Sulfate Hemihydrate (Csh)/multi-Walled Carbon Nanotube (MWCNT) Composites for Bone Reconstruction Application].

Cytocompatibility of the nanophase beta-tricalcium phosphate /collagen fibers composite

Different effects of nanophase and conventional hydroxyapatite thin films on attachment, proliferation and osteogenic differentiation of bone marrow derived mesenchymal stem cells

Enhanced biocompatibility of PLGA nanofibers with gelatin/nano-hydroxyapatite bone biomimetics incorporation.

In Vitro Biocompatibility and Osteoblast Differentiation of an Injectable Chitosan/Nano-Hydroxyapatite/Collagen Scaffold

Clinical Application of Nano-hydroxyapatete/collagen Composite